Predictions of survival up to 10 years after diagnosis for european women with breast cancer in 2000-2002.


Allemani, C; Minicozzi, P; Berrino, F; Bastiaannet, E; Gavin, A; Galceran, J; Ameijide, A; Siesling, S; Mangone, L; Ardanaz, E; Hédelin, G; Mateos, A; Micheli, A; Sant, M; EUROCARE Working Group, ; (2013) Predictions of survival up to 10 years after diagnosis for european women with breast cancer in 2000-2002. International journal of cancer Journal international du cancer, 132 (10). pp. 2404-12. ISSN 0020-7136 DOI: 10.1002/ijc.27895

Full text not available from this repository. (Request a copy)

Abstract

: Few studies have addressed longer-term survival for breast cancer in European women. We have made predictions of 10-year survival for European women diagnosed with breast cancer in 2000-2002. Data for 114,312 adult women (15-99 years) diagnosed with a first primary malignant cancer of the breast during 2000-2002 were collected in the EUROCARE-4 study from 24 population-based cancer registries in 14 European countries. We estimated relative survival at 1, 5, and 10 years after diagnosis for women who were alive at some point during 2000-2002, using the period approach. We also estimated 10-year survival conditional on survival to 1 and 5 years after diagnosis. Ten-year survival exceeded 70% in most regions, but was only 54% in Eastern Europe, with the highest value in Northern Europe (about 75%). Ten-year survival conditional on survival for 1 year was 2-6% higher than 10-year survival in all European regions, and geographic differences were smaller. Ten-year survival for women who survived at least 5 years was 88% overall, with the lowest figure in Eastern Europe (79%) and the highest in the UK (91%). Women aged 50-69 years had higher overall survival than older and younger women (79%). Six cancer registries had adequate information on stage at diagnosis; in these jurisdictions, 10-year survival was 89% for local, 62% for regional and 10% for metastatic disease. Data on stage are not collected routinely or consistently, yet these data are essential for meaningful comparison of population-based survival, which provides vital information for improving breast cancer control.<br/>

Item Type: Article
Faculty and Department: Faculty of Epidemiology and Population Health > Dept of Non-Communicable Disease Epidemiology
Research Centre: Cancer Survival Group
PubMed ID: 23047687
Web of Science ID: 315512300018
URI: http://researchonline.lshtm.ac.uk/id/eprint/333674

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
400Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item